Распространенность и факторы риска хронической болезни почек в Республике Тыва
Диссертация
Актуальность проблемы. Хроническая болезнь почек является важной медицинской и социальной проблемой современной медицины (Nissen-son A.R. et al., 2001; Coresh J. et al., 2003). Оказалось, что распространенность дисфункции почек значительно больше, чем предполагалось ранее, и достигает 5−11% в общей популяции (Jones С.A. et al., 1998; Verhave J.C. et al., 2004), а некоторые исследователи полагают… Читать ещё >
Список литературы
- Добронравов В.А. Клинические факторы, связанные с развитием микроальбуминурии у больных сахарным диабетом 1 типа // Нефрология. — 1998. Т.2, № 3. — С.63−66.
- Добронравов В.А. Риск развития микроальбуминурии у больных инсу-линонезависимым сахарным диабетом: значение клинических факторов // Нефрология. 1998. — Т.2, № 4. — С.63−69.
- Добронравов В.А. Диабетическая нефропатия // Нефрология. 2000. — Т.4, № 2. — С. 81−82.
- Добронравов В.А. Эпидемиология диабетической нефропатии: общие и региональные проблемы // Нефрология. 2002. — Т.6, № 1. — С. 16−22.
- Добронравов В.А., Карпова И. А. Частота протеинурии и артериальной гипертензии у больных сахарным диабетом 1 типа в Санкт-Петербурге // Нефрология. 1998. — Т.2, № 2. — С.78−80
- Добронравов В. А, Карпова И. А., Ковалева И. Г. и др. Частота развития микроальбуминурии у больных сахарным диабетом II типа // Нефрология. 1999. — Т. 3. — С. 41−42.
- Добронравов В.А., Жучихина А. А., Карпова И. А. и др. Нарушения ли-пидного состава крови у больных с сахарным диабетом 1 типа и неф-ропатией // Нефрология. 2001. — Т.5, № 1. — С.82−85.
- Добронравов В.А., Смирнов А. В., Драгунов С. В. и др. Эпидемиология хронической болезни почек в Вологодской области // Нефрология. -2004. Т.8, № 1. — С. 36−41.
- Добронравов В.А., Смирнов А. В., Драгунов С. В. и др. Эпидемиология хронической почечной недостаточности в Северо-Западном регионе России: на пути к созданию регистра хронической почечной болезни // Тер. арх. 2004. — Т.76, № 9. — С.57−61.
- Добронравов В. А, Царькова О. В. Блокаторы кальциевых каналов в нефропротекции // Нефрология. 2004. — Т.8, № 1. — С. 7−21.
- Есаян A.M. Тканевая ренин-ангиотензиновая система почки. Новая стратегия нефропротекции // Нефрология. 2002. — Т. 6, № 3. — С.8−16.
- Каюков И.Г., Есаян A.M., Кучер А. Г., Ермаков Ю. А. Роль функцио-нально-гемодинамических механизмов в прогрессировании хронического гломерулонефрита // Нефрология. 1998. — Т.2, № 1. — С. 7−13.
- Краснова Е.А., Моисеев С. В., Фомин В. В. Нефрологические аспекты проблемы ожирения // Клин. мед. 2005. — Т. 83, № 4. — С. 9−14.
- Кузьмин О.Б., Пугаева М. О., Чуб С.В. Легкая дисфункция почек у больных с эссенциальной гипертонией: клинические проявления и лекарственная терапия // Нефрология. 2004. — Т. 8, № 3. — С. 15−21.
- Кутырина И.М., Руденко Т. Е., Дзигоева М. Ю. Ремоделирование сосудов при хронической почечной недостаточности // Клинич. мед. -2005.- № 2. -С. 16−21.
- К проблеме лечения терминальной хронической почечной недостаточности в России. Первые итоги работы по созданию Российского национального регистра заместительной почечной терапии // Нефрология и диализ. 1999. — Т. 1, № 1. — С. 79−84.
- Мухин Н.А., Балкаров И. М., Моисеев С. В. и др. Хронические прогрессирующие нефропатии и образ жизни современного человека // Тер. арх. 2004. — Т.76, № 9. — С. 5−10.
- Мухин Н.А., Балкаров И. М., Лебедева М. В. и др. Уратная нефропатия -от «бессимптомной» гиперурикозурии до хронического гемодиализа // Нефрология. 1997. — Т.1, № 3. — С. 7−10.
- Общественное здоровье и здравоохранение / Под ред. В. А. Миняева, Н. И. Вишнякова. М.: МЕДпресс-информ, 2003. — 528 с.
- Пальцев М.А., Варшавский В. А., Максимов Н. А., Балкаров И. М. Морфологическая характеристика гиперурикемического варианта хронического гломерулонефрита // Арх. пат. 1988. — № 6. — С.8−15.
- Рентц Дун Б., Андерсон Ш., Бреннер Б. Гемодинамические основы прогрессировать почечных болезней // Современная нефрология. II международный нефрологический семинар. М., 1997. — С. 162−172.
- Рябов С.И. Болезни почек: Руководство для врачей. Л.: Медицина, 1982.-431 с.
- Рябов С.И. Нефрология: Руководство для врачей. СПб.: СпецЛит, 2000. — 672 с.
- Рябов С.И., Бондаренко Б. Б. Классификация хронической почечной недостаточности // Хроническая почечная недостаточность / Ред. С. И. Рябов. Л.: Медицина, 1976. — С. 21−33.
- Рябов С.И., Шишкин В. И. Классификация гломерулонефрита // Гломе-рулонефрит / Ред. С. И. Рябов. Л.: Медицина, 1980. — С.5−21.
- Смирнов АВ. Уремическая дислипопротеинурия // Нефрология. 1998. -Т. 2, № 1. — С. 15.
- Смирнов А.В., Добронравов В. А., Румянцев А. Ш., Мнускина М. М. Факторы риска ИБС у больных, получающих лечение гемодиализом // Нефрология. 2002. — Т. 7, Прил. 1. — С. 7−13.
- Смирнов А.В. Дислипопротеидемии и проблемы нефропротекции // Нефрология. 2002. — Т.6, № 2. — С. 8−14.
- Смирнов А.В. Хроническая болезнь почек или хроническое заболевание почек? // Нефрология. 2004. — Т.8, № 1. — С. 101−102.
- Смирнов А.В., Есаян A.M., Каюков И. Г. Хроническая болезнь почек: на пути к единству представлений // Нефрология. 2002. — Т.6, № 4. -С. 11−17.
- Смирнов А.В., Каюков И. Г., Есаян A.M. и др. Превентивный подход в современной нефрологии // Нефрология. 2004. — Т.8, № 3. — 7−14.
- Смирнов А.В., Добронравов В. А., Бодур-Ооржак А.Ш. и др. Эпидемиология и факторы риска хронических болезней почек: региональный уровень общей проблемы // Тер. арх. 2005. — № 6. — С. 20−27.
- Смирнов А.В., Добронравов В. А., Каюков И. Г. Кардиоренальный континуум: патогенетические основы превентивной нефрологии // Нефрология. 2005. — Т. 9, № 3. — С. 7−15.
- Смирнов А.В., Добронравов В. А., Голубев Р. В. и др. Распространенность гипергомоцистеинемии в зависимости от стадии хронической болезни почек // Нефрология. 2005. — Т.9, № 2. — С. 48−52.
- Смирнов А.В., Каюков И. Г., Есаян A.M. и др. Проблема оценки скорости клубочковой фильтрации в современной нефрологии: новый индикатор цистатин С // Нефрология. — 2005. — Т.9, № 3. — С. 16−27.
- Томилина Н.А., Бикбов Б. Т. Эпидемиология хронической почечной недостаточности и новые подходы к классификации и оценке тяжести хронических прогрессирующих заболеваний почек // Тер. арх. 2005. -Т. 77, № 6. — С. 87−92.
- Флетчер Р., Флетчер С., Вагнер Э. Клиническая эпидемиология. Основы доказательной медицины. М: Медиа Сфера, 1998. — 352 с.
- Шишкин А.Н., Кирилюк Д. В. Дисфункция эндотелия у пациентов с прогрессирующими заболеваниями почек // Нефрология. 2005. — Т.9, № 2. — С. 16−22.
- Шишкин А.Н., Бирюкова Е. Н., Гупалова Т. В., Иванов И. Г., Янченко Д. Е. Микроальбуминурия у больных с сердечной недостаточностью // Нефрология. 2002. — Т.6, № 4. — С. 70−73.
- Шюк О. Функциональное исследование почек. Прага: Авиценум, 1981.
- Adrissino G., Dacco V., Testa S. et al. Epidemiology of chronic renal failure in children: Date from the ItalKid Project // Pediatrics. 2003. — Vol. 111. — P. 1382−1387.
- Al Ahmad A., Rand W.M., Manjunath G. et al. Redused kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction // J. Am. Coll. Cardiol. 2001. — Vol. 38. — P. 955- 962.
- Alexander C.M., Lyle P.A., Keane W.F. et al. Losartan and the United State costs of end-stage renal disease by baseline albuminuria in patients with type 2 diabetes and nephropathy // Kidney Int. 2004. — Vol. 66, Suppl. 92. -P. S115-S117.
- Anavekar N.S., Pfeffer M.A. Cardiovascular risk in chronic kidney disease // Kidney Int. 2004. — Vol. 66, Suppl. 92. — P. SI 1-S15.
- Anavekar N.S., Me Murray J.V., Velazguez E.J. et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction // N. Engl. J. Med. 2004. — Vol. 351. — P. 13.
- Andreev E., Koopman M., Arisz L. A rise in plasma creatinine that is not a sign of renal failure- which drags can be responsible? // J. Intern. Med. -1999. Vol. 246, № 3. — P.247−252.
- Anonimous. Part 1. Executive Summary // Am. J. Kidney Dis. 2002. -Vol. 39 (suppl.l). — P. S17-S23.
- Arein M., Walls J. End-stage renal disease, Atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link? // Kidney Int. 2001. -Vol. 59.-P. 407−414.
- Arid M., Brown J., Williams M. et al. Fatty acids carried on albumin modulate proximal tubular cell fibronectin production: A role for protein kidnase С // Nephrol. Dial. Transplant. 2002. — Vol. 17. — P. 1751−1757.
- Atiyeh B.A., Dabbagh S.S., Gruskin A.B. Evaluation of renal function during childhood // Pediatr. Rev. 2001. — Vol. 17. — P. 175−179.
- Atkins R.C. The epidemiology of chronic kidney disease // Kidney Int. -2005. Vol. 67, Suppl. 94. — P. S14-S18.
- Beck L. Requiem for gouty nephropathy // Kidney Int. 1986. — Vol. 30. -P. 280−287.
- Berger L., Yii T. Renal function in gout: IV: An analysis of 524 gouty subjects including long-term follow-up studies // Am. J. Med. 1975. — Vol. 59. -P. 605−613.
- Bommer J. Prevalence and socio-economic aspects of chronic kidney disease // Nephrol. Dial. Transplant. 2002. — Vol. 17, Suppl. 11. — P. 8−12.
- Bongartz L.G., Cramer M.J., Doevendans P.A. et al. The severe cardiorenal syndrome: «Guyton revisited» // Eur. Heart. J. 2005. — Vol. 26. — P. 11−17.
- Brenner B.M., Cooper M.E., De Zeew D. et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy // N. Engl. J. Med. 2001. — Vol. 345. — P. 861−869.
- Carlson J.A., Harrington J.T. Laboratory evaluation of renal function. In: Schrier R.W., Gottschalk C.W., eds. Disease of the kidney, fifth ed. Little, Brown&Co, Boston e.a., 1993. P. 361−405.
- Chen J., Muntner P., Hamm L.L. et al. The metabolic syndrome and chronic kidney disease in U.S. adults // Ann. Intern. Med. 2004. — Vol. 140, № 3. -P. 167−174.
- Cockcroft D.W., Gault M.H. Prediction of creatinine from serum creatinine // Nephron. 1976. — Vol.16, № 1. — P.31−41.
- Chen J., Munter P., Hamm L.Z. et al. The metabolic syndrome and chronic kidney disease in US adults // Ann. Intern. Med. 2004. — Vol. 140. — P. 167−174.
- Coresh J., Astor B.C., McQuillian G. et. al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate // Am. J. Kidney Dis. 2002. — Vol.39, № 5. -P.l-11.
- Coresh J., Astor B.C., Greene T. et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey // Am. J. Kidney Dis. 2003. -Vol. 41, № 1.-P. 1−12.
- Coresh J., Byrd-Holt D., Astor B.C. et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000 // J. Am. Soc. Nephrol. 2005. — Vol. 16, № 1. — P.180−188.
- Damsgaard E.M., Froland A., Jorgensen O.D., Mogensen C.E. Microalbuminuria as predictor of increased mortality in elderly people // BMJ. 1990. -Vol. 300. — P.297−300.
- Deleau J., Andre J.L., Briancon S., Musse J.P. Chronic renal failure in children: an epidemiological survey in Lorraine (France) // Pediatr. Nephrol. -1994. Vol. 11. — P. 472−476.
- De Vecchi A.F., Drratwa M., Weidemann ME. Healthcare system and end-stage renal disease (ESRD) therapies an international review. Costs and reimbursement/funding of ERSD therapies // Nephrol. Dial. Transplant. -1999. — Vol. 14, Suppl. 6. — P. 31−41.
- Devereux R.B., Alonso D.R., Lutas E.M. et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings // Am. J. Cardiol. 1986. — Vol. 57. — P. 450−458.
- European Best Practice Guidelines, Expert Group on Hemodialysis, European Renal Association. Section I. Measurement of renal function, when to refer and when to start dialysis // Nephrol. Dial. Transplant. 2002. — Vol. 17, Suppl. 7.-P. 7−15.
- Eustace J.A., Astor В., Muntner P.M., Ikizler T.A., Coresh J. Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease // Kidney Int. 2004. — Vol. 65, № 3. — P. 10 311 040.
- Erlinger T.P., Tarver-Carr M.E., Powe N.R. et al. Leukocytosis, hypo-albuminemia, and the risk for chronic kidney disease in US adults // Am. J. Kidney Dis. 2003. — Vol. 42, № 2. — P. 256−263.
- Esbjorner E., Aronson A., Berg U. et al. Children with chronic failure in Sweden 1978−1985 // Pediatr. Nephrol. 1990. — Vol. 4. — P. 249−252.
- Esbjorner E., Berg U., Hansson S. Epidemiology of chronic renal failure in children: a report from Sweden 1986−1994 // Pediatr. Nephrol. 1997. -Vol. 11.-P. 438−442.
- Feest T.G., Mistry C.D., Grimes D.S. et al. Incidence of advanced chronic renal failure and the need for end stage renal replacement treatment // Brit. Med. J. 1990. — Vol. 301. — P. 897−900.
- Foley R.N., Parfrey P. S., Sarnak M.J. Epidemiology of cardiovascular disease in chronic renal disease // J. Am. Soc. Nephrol. 1998. — Vol. 9, Suppl. 12. -P. S16-S23.
- Foley R.N., Wang C., Collins A.J. Cardiovascular risk factor profiles and kidney function stage in the US general population: the NHANES III study // Mayo Clin. Proc. 2005. — Vol. 80, № 10. — P. 1270−1277.
- Fouque D., Wang P., Laville M., Boissel J.P. Low protein diets delay end-stage renal disease in non-diabetic adults with chronic renal failure // Nephrol. Dial. Transplant. 2000. — Vol. 15. — P.1986−1992.
- Fox C.S., Larson M.G., Leip E.P. et al. Predictors of new-onset kidney disease in a community-based population // JAMA. 2004. — Vol.291, № 7. -P.844−50.
- Fried Z.F., Orchard T.J., Kasiske B.Z. Effect of lipid reduction on the progression of renal disease: a meta- analysis // Kidney Int. 2001. — Vol. 59. -P. 260−269.
- Friedman A.N., Boston A.G., Selhub J. et al. The Kidney and homocysteine metabolism//J. Am. Soc. Nephrol. 2001. — Vol. 12. — P. 2181−2189.
- Henry R.M., Kostense P.J., Bos G. et al. Mild renal in sufficiency is associated with increased cardiovascular mortality: the Hoorn Study // Kidney Int. 2002. — Vol. 62. — P. 1402−1407.
- Gehan E., George S.L. Estimation of human body surface area from height and weight // Cancer Chemother Rep. 1970. — Vol. 54, № 4. — P. 225−235.
- Gibson C.M., Pinto D.S., Murphy S.A. et al. TIMI Study Group: Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subseguent mortality // J. Am. Coll. Cardiol. 2003. — Vol. 42. -P. 1535−1543.
- Go A.S., Chertow G.M., Fan D., McCulloch C.E., Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization // N. Engl. J. Med. 2004. — Vol. 351, № 13. — P. 1296−305.
- Goldsmith D., MacGinley R., Smith A., Covic A. How important and now treatable is vascular stiffness as a cardiovascular risk factor in renal failure? // Nephrol. Dial. Transplant. 2002. — Vol. 17. — P. 965- 969.
- Gonick HC, Rubini MD, Gleason IO, Sommers SC: The renal lesion in gout // Ann. Int. Med. 1965. — Vol.62. — P.667−674.
- Goumenos D.S., Kalliakmani P., Tsakas S. et al. The remission of nephrotic syndrome with cyclosporin treatment does not attenuate the progression of idiopathic membranous nephropathy // Clin. Nephrol. 2004. — Vol. 61, № 1. — P. 17−24.
- Groothoff J.W., Grootenhuis M.A., Offringa M. et al. Social consequences in adult life of end-stage renal disease in childhood // J. Pediatr. 2005. -Vol. 146, № 4.-P. 512−517.
- Groothoff J.W. Late somatic and psycho-social consequences of renal insufficiency in children // EDTNA ERCA J. 2004. — Vol. 30, № 4. — P. 222 225.
- Halimi J.M., Forhan A., Balkan B. et al. Ig microalbuminuria an integrated risk marker for cardiovascular disease and insulin resistance in both men and women? // J. Cardiovasc. Risk. 2001. — Vol. 8. — P. 139- 146.
- Haroun N.K., Jaar B.G., Hoffman S.C. et al. Risk factors for chronic Kidney disease: a prospective study of 23.534 men and women in Washington Country, Maryland // J. Am. Soc. Nephrol. 2003. — Vol. 14. — P. 29 342 941.
- Hayashi Т., Suzuki A., Shoji T. et al. Cardiovascular effect of normalizing the hematocrit level during erythropoethin in predialysis patients with chronic renal failure // Am. J. Kidney Dis. 2000. — Vol. 35. — P. 250−256.
- Hegarty J, Foley RN. Anaemia, renal insuffiency and cardiovascular outcome // Nephrol. Dial. Transplant. 2001. — Vol. 16, Suppl. 1. — P. 102−104.
- Hillege H.L., Fidler V., Diercks G.F. et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population // Circulation. 2002. — Vol. 106. — P. 1777−1782.
- Henry R.M., Kostense P.J., Bos G. et al. Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn Study // Kidney Int. 2002. — Vol. 62. — P. 1402−1407.
- Herman W.H., Shahinfar S., Carides G.W. et al. Losartan reduces the costs associated with diabetic end-stage renal disease: the RENAAL study economic evaluation // Diabetes Care. 2003. — Vol. 26, № 3. — P. 683−687.
- Hsu C.Y., Lin F., Vittinghoff E., Shlipak M.G. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States // J. Am. Soc. Nephrol. 2003. — Vol.14, № 11. — P.2902−2907.
- Iseki K., Iseki C., Ikemmiya Y. et al. Risk of development end-stage renal disease in a cohort mass screening // Kidney Int. 1996. — Vol. 49. — P. 800 805.
- Jafar Т.Н., Schmid C.H., Landa M. et al. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data // Ann. Intern. Med. 2001. — Vol. 135. — P. 73−87.
- Johnson R.J., Kivlighn S.D., Kim Y.-G., Suga S., Fogo A. Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease // Am. J. Kid. Dis. 1999. — Vol.33. — P. 225−234.
- Jones С.A., McQuillan G.M., Kusek J.W. et al. Serum creatinine levels in the US population: Third National Health and Nutrition Examination Survey // Am. J. Kidney Dis. 1998. — Vol. 32. — P. 992−999.
- Jones C.A., Krolewski A.S., Rogus J. et al. Epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause? // Kidney Int. 2005. — Vol. 67, № 5. — P. 1684−1691.
- Jungers P., Chauveau P., Descamps-Latscha B. et al. Age and gender-related incidence of chronic renal failure in a French urban area: a prospective epidemiologic study // Nephrol. Dial. Transplant. 1996. — Vol. 11. — P. 15 421 546.
- Kalantar-Zadeh K., Block G., Horwich Т., Fonarow G.C. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure // J. Am. Coll. Cardiol. 2004. — Vol. 48. — P. 1439- 1444.
- Kamijo A., Kimura K., Sugaya T. et al. Urinary free fatty acids bound to albumin aggravate tubulointerstitial damage // Kidney Int. 2002. — Vol. 62. -P. 1628−1637.
- Kang D.H., Nakagawa Т., Feng L. et al. A role for uric acid in the progression of renal disease // J. Am. Soc. Nephrol. 2002. — Vol.13, № 12. -P.2888−2897.
- Kasiske B.L., Keane W.F. Laboratory assessment of renal disease: clearance, urinalysis, and renal biopsy // The kidney / Ed. B.M. Brenner. 5th ed. — Brenner&Rector, W.B. Saunders, 1998. — P. 21 477−22 269.
- Kees-Folts D., Sadow J.L., SchreinerGf. Tubular catabolism of albumin is associated with the release of an inflammatory lipid // Kidney Int. 1994. -Vol. 45. — P.1697−1709.
- Keith D.S., Nichols G.A., Gullion C.M., Brown J.B., Smith D.H. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization // Arch. Intern. Med. 2004. -Vol.164, B.M. 6. -P.659−663.
- Kemperman F.A., Silberbusch J., Slaats E.H. et al. Glomerular filtration rate estimation from plasma creatinine after inhibition of tubular secretion: relevance of creatinine assay // Nephrol. Dial. Transplant. 1999. — Vol. 14. -P. 1247−1251.
- Kemperman F.A., Silberbusch J., Slaats E.H. et al. Estimation of the glomerular rate in NIDDM patient from plasma creatinine concentration after ci-metidine administration // Diabetes Care. 1998. — Vol.21, № 2. — P.216−220.
- Levey A.S., Berg R.L., Gassman J.J. et al. Creatinine filtration, secretion and excretion during progressive renal disease // Kidney Int. 1989. — Vol. 36, Suppl. 27.-P. S73-S80.
- Levey A.S., Bosch J.P., Lewis J.B. A more accurate method to estimate glomerular filtration rate from serum creatinine- a new prediction equation //Ann. Intern. Med. 1999. — Vol. 130, № 8. — P. 461−470.
- Levey A.S., Greene Т., Kusek J.W., Beck G.J. A simplified equation to predict glomerular filtration rate from serum creatinine // J. Am. Soc. Nephrol. 2000. — Vol. 11. — A0828 (abstr).
- Lewis E.J., Hunsicker L.G., Clarke W.R. et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes // N. Engl. J. Med. 2001. — Vol.345. — P. 851−860.
- Lin C.Y., Sheng C.C., Chen C.H. et al. The prevalence of heavy proteinuria and progression risk factors in children undergoing urinary screening // Pe-diatr. Nephrol. 2002. — Vol. 14. — P. 953−959.
- Linder A., Charka В., Sherrazd D.J., Scribner B.H. Accelerated atherosclerosis in prolonged maintenance hemodialysis // N. Engl. J. Med. 1974. -Vol. 290.-P. 679−701.
- Locatelli F., DAmico M., Cernevskis H. et al. The epidemiology of end-stage renal disease in the Baltic countries: an evolving picture // Nephrol. Dial. Transplant. 2001. — Vol. 16. — P. 1338−1342.
- Locatelli F., Del Vecchio L. How long can dialysis be postponed by low protein diet and ACE ihibitors? // Nephrol. Dial. Transplant. 1999. — Vol. 14.-P. 1360−1364.
- Locatelli F., Marcelli D., Conte F. et al. For the Registro Lombardo Dialisi e Trapianto. Cardiovascular disease in chronic renal failure: the challenge continues // Nephrol. Dial. Transplant. 2000, Vol. 15, Suppl 5. — P. S69−80.
- Locatelli F., Valderrabano F., Hoenich N. et al. Progress in dialysis technology: membrane selection and patient outcome // Nephrol. Dial. Transplant. — 2000. Vol. 15. — P. 1133−1139.
- Locatelli F., Del Vecchio L., D’Amico M., Andrulli S. Is it the agent or the pressure level that matters for renal protection in chronic nephropathies? // J. Am. Soc. Nephrol. 2002. — Vol. 13, Suppl. 18. — P.
- Locatelli F., Del Vecchio L., Pozzoni P. The importance of early detection of chronic kidney disease // Nephrol. Dial. Transplant. 2002. — Vol. 17, Suppl. 11.-P. 2−7.
- Locatelli F., Pozzoni P., Del Vecchio L. Epidemiology of chronic kidney disease in Italy: Possible therapeutical approaches // J. Nephrol. 2003. -Vol. 16.-P. 1−10.
- Lysaght M.J. Maintenance dialysis population dynamics: current trends and long-term implications // J. Am. Soc. Nephrol. 2002. — Vol. 13, Suppl. 1. -P. S37−40.
- Majunath G., Tighionart H., Corest F. Level of kidney function as a risk factors for cardiovascular outcomes in the elderly // Kidney Int. 2003. — Vol. 63. -P.1121−1129.
- Majunath G., Tighionart H., Ibrahim H. et al. Level of kidney function as a risk factors for atherosclerotic cardiovascular outcomes in the community // J. Am. Coll. Cardiol. 2003. — Vol. 41. — P. 47- 55.
- Mazzali M., Kanellis J., Han L. et al. Hyperuricemia induces a primary arte-riolopathy in rats by a blood pressure-independent mechanism // Am. J. Physiol. Renal Physiol. 2002. — Vol. 282. — P. F991-F997.
- McClellan W.M., Ramirez S.P.B., Jurkovitz C. Screening of chronic kidney disease: Unresolved question // J. Am. Soc. Nephrol. 2003. — Vol. 14. — P. S81-S87.
- McDonald S.P., Craig J.C. Long-term survival of children with end-stage renal disease // N. Engl. J. Med. 2004. — Vol. 350. — P. 2654−2662.
- Menon V., Greene Т., Wang X. et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease // Kidney Int. 2005. — Vol.68, № 2. — P.766−72.
- Menon V., Wang X., Green T. et al. Relation skip between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease // Am. J. Kidney. Dis. 2003. — Vol.42. — P. 44−52.
- Moeller S., Gioberge S., Brown G. ESRD patients in 2001: Global overview of patients, treatment modalities and development trends // Nephrol. Dial. Transplant. 2002. — Vol. 17. — P. 2071−2076.
- Muggeo G., Verlato G., Bonora E. et al. The Verona diabetes study: a population-based survey on known diabetes mellitus prevalence and 5-year all cause mortality // Diabetilogia. 1995. — Vol.38. — P.318−325.
- Muntner P., Coresh J., Smith J.C. et al. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study // Kidney Int. 2000. — Vol. 58. — P. 293−301.
- Mogensen C.E. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes // N. Engl. J. Med. 1984. — Vol. 310. -P.356−360.
- Mourad J.J., Pannier В., Blacher J. et al. Creatinine clearance, pulse wave velocity, carotid compliance and essential Hypertension // Kidney Int. -2001.-Vol. 59.-P. 1834−1841.
- Murakami M., Yamamoto H., Ueda I. et al. Urinary screening of elementary and junior high-school children over a 13-year period in Tokyo // Pediatr. Nephrol. 1991. — Vol. 5. — P. 50−53.
- Murakami M., Hayakawa M., Yanagihara Т., Hukunaga Y. Proteinuria screening for children // Kidney Int. 2005. — Suppl. 94. — P. S23-S27.
- National Kidney Foundation KD: Clinical practice guidelines for chronic Kidney disease: Evaluation, classification and stratification // Am. J. Kidney Dis. -2002. Vol. 39, Suppl. 1. — P. S1-S266.
- Nickeleit V., Mihatsch M.J. Uric acid nephropathy and end stage renal disease: Review of a non-disease // Nephrol. Dial. Transpl. 1997. — Vol.12. -P. 1832−1838.
- Norris K., Vaughn C. The role of renin-angiotensin-aldosterone system in chronic kidney disease //Expert. Rev. Cardiovasc. Ther. 2003. — Vol. 1, № 1. — P. 51−63.
- Oken D.E. Criteria for the evaluation of the severity of established renal disease // Nephron. 1970. — Vol.7, № 5. — P.385.
- Orth S.R. Smoking and the kidney // J. Am. Soc. Nephrol. 2002. — Vol. 13. -P. 1663−1672.
- Palmer A.J., Rodby R.A. Health economic studies assessing irbesartan use in patients with hypertension, type 2 diabetes, and microalbuminuria // Kidney Int. 2004. — Vol. 66, Suppl. 92. — P. S118-S120.
- Parekh R.S., Carroll C.E., Wolfe R.A., Port F.K. Cardiovascular mortality in children and yang adults with end stage renal disease // J. Pediatr. 2002. -Vol. 141.-P. 191−197.
- Perera G.A. Hypertensive vascular disease: description and natural history // J. Chron. Dis. 1955. — Vol. 1. — P. 33−42.
- Perez-Ruiz F., Calabozo M., Fernandez-Lopez M.J. et al. Treatment of chronic gout in patients with renal function impairment. An open, randomized actively controlled study // J. Clin. Rheumatol. 1999. — Vol. 5. — P. 49−55.
- Perrone R.D., Madias N.E., Levey A.S. Serum creatinine as an index of renal function: new insights into old concepts // Clin. Chem. 1992. — Vol. 38, № 10.-P. 1933−1953.
- Pinto-Siersma S.J., Mulder J., Janssen W.M. et al. Smoking is related to albuminuria and abnormal renal function in nondiabetic persons // Ann. Intern. Med. 2000. — Vol. 133. — P. 585−591.
- Portoles J., Torralbo A., Martin P. et al. Cardiovascular effect recombinant human erythropoetin in predialysis patients // Am. J. Kidney Dis. 1997. -Vol. 29.-P. 541−548.
- Rosenfeld J.B. Effect of long-term allopurinol administration on serial GFR in normotensive and hypertensive hyperuricemic subjects // Adv. Exp. Med. Biol. 1974. — Vol. 41. — P. 581−596.
- Qureshi A.R., Alvestrand A., Divino-Filho J.C. et al. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients // J. Am. Soc. Nephrol. 2002. — Vol.13, Suppl. 1. — P. S28−36.
- Ritz E. Renal dysfunction as a novel risk factor: microalbuminuria and cardiovascular risk // Kidney Int. 2005. — Vol. 67, Suppl. 3. — P. S25−28.
- Ritz E., Dikow R., Ruilope L.M. Renal dysfunction as a cardiovascular risk factor // Curr. Hypertens. Rep. 2002. — Vol. 4. — P. 365−368.
- Rodrigo E., Martin de Fracisco A.L., Escallada R. et al. Measurement of renal function in pre-ERSD patients // Kidney Int. 2002. — Vol. 61, Suppl. 80.-P. S11-S17.
- Rosansky S.J., Jackson K. Rate of change of end-stage renal disease treatment incidence 1978−1987 has there been selection? //J. Am. Soc. Nephrol. -1992. Vol. 2, № 10. — P. 1502−1506.
- Ruelope Z.M., Salvetti A., Jamerson K. et al. Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOJ) study // J. Am. Soc. Nephrol. 2001. — Vol.12. — P. 218−225.
- Ruilope L.M., Segura J. Losartan and other angiotensin П antagonists for nephropathy in type 2 diabetes mellitus: a review of the clinical trial evidence // Clin. Ther. 2003. — Vol. 25, № 12. — P. 3044−3064.
- Rutkowski B. Changing pattern of end-stage renal failure in Central and Eastern Europe // Nephrol. Dial. Transplant. 2002. — Vol. 15. — P. 156−160.
- Safar M.E., Henry O., Meanme S. Aortic pulse wave velocity: an independent marker of cardiovascular risk // Am. J. Geriatr. Cardiol. 2002. — Vol. 11.-P. 295−298.
- Sakhuja V., Sub K. End-sage renal disease in India and Pakistan: Burden of disease and management issues // Kidney Int. 2003. Vol. 63, Suppl. 83. -P. 115−118.
- Sanchez-Lozada L.G., Tapia E., Santamaria J. et al. Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats // Kidney Int. 2005. — Vol. 67, № 1. — P.237−247.
- Sarnak M.J., Levey A.S. Cardiovascular disease and chronic renal disease: A new paradigm // Am. J. Kidney Dis. 2000. — Vol. 35, Suppl.l. — P. SI 17-S131.
- Sarnak M.J., Cornado B.E., Greene T. et al. Cardiovascular disease risk factors in chronic renal insufficiency // Clin. Nephrol. 2002. — Vol. 57. -P.327−335.
- Segura J., Campo C., Ruilope L.M. Chronic kidney disease and global cardiovascular risk in essential hypertension // Minerva Med. 2004. — Vol. 95, № 5. — P.375−383.
- Schaeffner E.S., Kurth Т., Curhan G.C. et al. Cholesterol and the risk of renal dysfunction in apparently healthy men // J. Am. Soc. Nephrol. 2003. -Vol. 14.-P. 2084−2091.
- Schena F.P. Epidemiology of end-stage renal disease: International comparisons of renal replacement therapy // Kidney Int. 2000. — Vol.57, Suppl.74.- P. S39-S45.
- Schiepati A., Remuzzi G. Chronic renal disease as a public health problem: Epidemiology, social and economic implications // Kidney Int. 2005. -Vol. 68, Suppl. 98. — P. S7-S10.
- Schuck O., Stribrna J., Teplan V. et al. Long-term follow-up of the tubular secretion of creatinine in renal graft recipients // Physiol. Res. 1998. — Vol. 47.-P. 419−426.
- Seng W.K., Hwang S.J., Han D.C. et al. Losartan reduces the costs of diabetic end-stage renal disease: an Asian perspective // Nephrology (Carlton).- 2005. Vol. 10, № 5. p. 520−524.
- Smith D.H., Gullion C.M., Nichols G. et al. Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population // J. Am. Soc. Nephrol. 2004. — Vol. 15, № 5. — P. 1363−1364.
- Serdar M.A., Kurt I., Ozcelik F. et al. A practical approach to glomerular filtration rate measure creatinine clearance estimation using cimetidine // Ann. Clin. Lab. Sci. -2001. Vol. 31, № 3. — P. 265−273.
- Stenvinkel P., Heimburger O., Paultre F. et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure // Kidney Int. 1999. — Vol. 55, № 5. — P. 1899−1911.
- Stuveling E.M., Bakker S.J., Hilige H.X. et al. Biochemical risk markers: a novel area for better prediction of renal risk? // Nephrol. Dial. Transplant. -2005. Vol. 20. — P. 497−508.
- Stuveling E.M., Hillege H.L., Bakker S.J. et al. C-reactive protein is associ-, / ated with renal function abnormalities in a non-diabetic population // Kidney1.t. -2003. Vol. 63, № 2. — P.654−61.
- Szucs T.D., Sandoz M.S., Keusch G.W. The cost-effectiveness of losartan in type 2 diabetics with nephropathy in Switzerland an analysis of the RENAAL study // Swiss Med. Wkly. 2004. — Vol. 134, № 31−32. — P. 440−447.
- Talbott J.H., Terplan K.L. The kidney in gout // Medicine. 1960. — Vol.39. -P. 405−467.
- Trevisan R., Vedovato M., Tiengo A. The epidemiology of diabetes mellitus // Nephrol. Dial. Transplant. 1998. — Vol.13, Suppl.8. — P.2−5.
- U.S. Renal Data System. USRDR 2000 Annual Data Report, Bethesda, MD, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2000.
- U.S. Renal Data System. USRDR 2004 Annual Data Report, Bethesda, MD, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2004.
- Verhave J.C., Hillege H.Z., Burgerhof G.M. et al. The association between atherosclerotic risk factors and renal function in the general population // Kidney Int. 2005. — Vol. 67. — P. 1967−1973.
- Walker R.J. Paediatric report // Disney A.P.S. ed. The twenty second reports: Australian and New Zealand Dialysis and Transplantation Registry. 1999. Adelaide, Australia: ANZDATA Registry, 1999. — P. 90−97.
- Walser M. Assessing renal function from creatinine measurements in adults with chronic renal failure // Am. J. Kidney Dis. 1998. — Vol. 32, № 1. — P. 23−31.
- Wyss M., Kaddurah-Daouk R. Creatine and creatinine metabolism // Physiol. Rev. 2000. — Vol. 80, № 3. — P. 1107−1213.
- Xue J.L., Ma J.Z., Louis T.A., Collins A J. Forecast of the number of patients with end-stage renal disease in the United States to the year 2010 // J. Am. Soc. Nephrol. 2001. — Vol. 12. — P. 2753−2758.
- Yap H.K., Quek C.M., Shen Q. et al. Role of urinary screening programmes in children in the prevention of chronic kidney disease // Ann. Acad. Med. Singapore. 2005. — Vol. 34. — P. 3−7.
- Zavie C.J., Milani R.V. Obesity and cardiovascular disease: the Hyppocrates paradox? //J. Am. Coll. Cardiol. 2003. — Vol. 42. — P. 677−679.
- Zimmerman J., Herrlinger S., Pruy A. et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients // Kidney Int. 1999. -Vol. 55. — P. 648−658.
- Zingo G., Biasucci Z.M., Gallimore J.R. et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina // N. Engl. J. Med. 1994. — Vol. 331. — P.417−424.
- Zoccali C. Cardiorenal risk as a new frontier of nephrology: research needs and areas for intervention // Nephrol. Dial. Transplant. 2002. — Vol. 17, Suppl. 11.-P. 50−54.